Abstract
Meta-analysis is a quantitative approach for systematically combining the results of previous studies in order to arrive at conclusions about the body of research. It answers a specific research question, includes an explicit methodology section, employs strategies to minimize bias, yields objective findings and enables evidence-based decisions. In this review, we examine meta-analysis taking examples from the field of cancer chemoprevention, an innovative area of cancer research that focuses on the prevention of cancer through pharmacological, biologic, and nutritional interventions. In particular, we consider the practical steps involved in the conduct of a meta-analysis, illustrate the statistical techniques for the calculation of summary estimates, present the available methodology for detecting and minimizing bias and, finally, we discuss unresolved issues and future applications.
Keywords: meta-analysis, bias, heterogeneity, cancer, chemoprevention, randomized clinical trials, chemotherapy trials, statistic, stratification, individual patient data
Current Drug Targets
Title: Developing the Evidence Base for Cancer Chemoprevention: Use of Meta-Analysis
Volume: 12 Issue: 13
Author(s): Georgios K. Nikolopoulos, Pantelis G. Bagos and Stefanos Bonovas
Affiliation:
Keywords: meta-analysis, bias, heterogeneity, cancer, chemoprevention, randomized clinical trials, chemotherapy trials, statistic, stratification, individual patient data
Abstract: Meta-analysis is a quantitative approach for systematically combining the results of previous studies in order to arrive at conclusions about the body of research. It answers a specific research question, includes an explicit methodology section, employs strategies to minimize bias, yields objective findings and enables evidence-based decisions. In this review, we examine meta-analysis taking examples from the field of cancer chemoprevention, an innovative area of cancer research that focuses on the prevention of cancer through pharmacological, biologic, and nutritional interventions. In particular, we consider the practical steps involved in the conduct of a meta-analysis, illustrate the statistical techniques for the calculation of summary estimates, present the available methodology for detecting and minimizing bias and, finally, we discuss unresolved issues and future applications.
Export Options
About this article
Cite this article as:
K. Nikolopoulos Georgios, G. Bagos Pantelis and Bonovas Stefanos, Developing the Evidence Base for Cancer Chemoprevention: Use of Meta-Analysis, Current Drug Targets 2011; 12 (13) . https://dx.doi.org/10.2174/138945011798184191
DOI https://dx.doi.org/10.2174/138945011798184191 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Combining Diffusion-Weighted Imaging Patterns with ABCD2 Score Predicts Stroke Risk after Transient Ischemic Attack
Current Neurovascular Research Arrhythmias and Left Ventricular Hypertrabeculation/Noncompaction
Current Pharmaceutical Design Transplantation of Adipose Tissue-Derived Stem Cells for Treatment of Focal Cerebral Ischemia
Current Neurovascular Research Intravascular Targeting of a New Anticoagulant Heparin Compound
Cardiovascular & Hematological Disorders-Drug Targets Anti-Bacterial Drug Discovery Using Systems Biology
Mini-Reviews in Medicinal Chemistry Optimized Turmeric Extracts have Potent Anti-Amyloidogenic Effects
Current Alzheimer Research Nanomaterial Based Approaches for the Diagnosis and Therapy of Cardiovascular Diseases
Current Pharmaceutical Design Atherosclerosis - New Targets and Therapeutics
Current Medicinal Chemistry - Cardiovascular & Hematological Agents PDE5 Inhibitors in Non-Urological Conditions
Current Pharmaceutical Design Pharmacological Approaches of Alzheimer's Disease: An Update
Current Drug Therapy Clinically Relevant Drug Interactions with Anti-Alzheimer's Drugs
CNS & Neurological Disorders - Drug Targets The GH/IGF-1 Axis and Heart Failure
Current Cardiology Reviews Adverse Drug Reactions in a Pulmonary Teaching Hospital: Incidence, Pattern, Seriousness, and Preventability
Current Drug Safety Bioavailability of Quercetin: Problems and Promises
Current Medicinal Chemistry Therapeutic Potential of Stem/Progenitor Cells in Human Skeletal Muscle for Cardiovascular Regeneration
Current Stem Cell Research & Therapy Thiazide Diuretics: 50 Years and Beyond
Current Hypertension Reviews Clinically Relevant Extracellular-Matrix Scaffolds for Cell Transplantation and Vascular Repair
Current Vascular Pharmacology Antiangiogenesis Drug Design: Multiple Pathways Targeting Tumor Vasculature
Current Medicinal Chemistry Obesity Pharmacotherapy: Current Perspectives and Future Directions
Current Cardiology Reviews Towards an Experimental and Systems Biology Framework for Cancer Cell Therapeutics
Current Bioinformatics